Company intelligence / Profile preview

Orphan Reach

Milton Keynes, England, United Kingdomorphan-reach.com ↗

Ownership: Private
Development stage: Other

Overview

Orphan Reach specializes in providing end-to-end clinical research services focused on rare diseases and orphan drugs. The company has built a reputation for rescuing challenging studies and supporting patient recruitment/retention in small populations. It operates globally and was acquired by Emmes in 2021 to expand its reach and capabilities.

Therapeutic areas: OtherRare Diseases
Industry: Contract Research Organization

Partnerships

Emmes (parent company)Neox (collaborative partner within Emmes group)

Beyond the preview

Go deeper on Orphan Reach.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Orphan Reach.

Explore the full profile